Inflammation

Items 1-10 of 26

Page
per page
Set Descending Direction
  1. anti-ACE2 (human), mAb (AC18F)
    AG-20A-0032
    AG-20A-0032-C05050 µg
    CHF 270.00
    AG-20A-0032-C100100 µg
    CHF 350.00
    FACS: HepG2 cells were stained significantly using anti-ACE2 (human), mAb (AC18F) (Prod. No. AG-20A-0032).
  2. anti-ACE2 (human), mAb (AC18F) (ATTO 488)
    AG-20A-0032TD
    AG-20A-0032TD-T100100 tests
    CHF 460.00
    anti-ACE2 (human), mAb (AC18F) (ATTO 488)
  3. anti-ACE2 (human), mAb (AC18F) (ATTO 647N)
    AG-20A-0032TS
    AG-20A-0032TS-T100100 tests
    CHF 460.00
    anti-ACE2 (human), mAb (AC18F) (ATTO 647N)
  4. anti-ACE2 (human), mAb (AC18F) (Biotin)
    AG-20A-0032B
    AG-20A-0032B-C05050 µg
    CHF 350.00
    FACS: HepG2 cells were stained significantly using anti-ACE2 (human), mAb (AC18F) (Biotin) (Prod. No. AG-20A-0032B).
  5. anti-IL-17A (human), mAb (17-142F)
    AG-20A-0071
    AG-20A-0071-C05050 µg
    CHF 270.00
    FACS: Human PBMCs were cultured with recombinant IL-1β, TGF-β, and IL-6 for 4 days. Cells were then reactivated with PMA/Ionomycin in the presence of monensin for 5h. Cells were stained with anti-IL-17A (human), mAb (17-142F) (FITC) (Prod. No. A
  6. anti-IL-17A (human), mAb (17-142F) (FITC)
    AG-20A-0071F
    AG-20A-0071F-C05050 µg
    CHF 350.00
    FACS: Human PBMCs were cultured with recombinant IL-1β, TGF-β, and IL-6 for 4 days. Cells were then reactivated with PMA/Ionomycin in the presence of monensin for 5h. Cells were stained with anti-IL-17A (human), mAb (17-142F) (FITC) (Prod. No. A
  7. anti-LAG-3 (human), mAb (17B4) (ATTO 488)
    AG-20B-0012TD
    AG-20B-0012TD-T100100 tests
    CHF 490.00
    Detection of endogenous human LAG-3 by FACS analysis using anti-LAG-3 (human), mAb (17B4) (ATTO 488) (Prod. No. AG-20B-0012TD). 
Human PBMC were stimulated (B) or not (A) with 1μg/ml of superantigen SEB. After 2 days, PBMC were stained with 10&mu
  8. anti-LAG-3 (human), mAb (17B4) (ATTO 647N)
    AG-20B-0012TS
    AG-20B-0012TS-T100100 tests
    CHF 490.00
    Detection of endogenous human LAG-3 by FACS analysis using anti-LAG-3 (human), mAb (17B4) (ATTO 647) (Prod. No. AG-20B-0012TS).
Human PBMC were stimulated (B) or not (A) with 1μg/ml of superantigen SEB. After 2 days PBMC were stained with 10μg
  9. anti-LAG-3 (human), mAb (17B4) (FITC)
    AG-20B-0012F
    AG-20B-0012F-C100100 µg
    CHF 480.00
  10. anti-LAG-3 (human), mAb (blocking) (17B4)
    AG-20B-0012
    AG-20B-0012-C100100 µg
    CHF 470.00

Items 1-10 of 26

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.